Graves Disease Clinical Trials

21 recruiting

Graves Disease Trials at a Glance

22 actively recruiting trials for graves disease are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Gothenburg, Baltimore, and Basel. Lead sponsors running graves disease studies include Vastra Gotaland Region, Biohaven Therapeutics Ltd., and Betul Uner.

Browse graves disease trials by phase

Treatments under study

About Graves Disease Clinical Trials

Looking for clinical trials for Graves Disease? There are currently 21 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Graves Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Graves Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting
Phase 1

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

Graves Disease
Merida Biosciences100 enrolled7 locationsNCT07305818
Recruiting

Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease

Graves DiseaseGraves Ophthalmopathy
Elazıg Fethi Sekin Sehir Hastanesi100 enrolled1 locationNCT07480720
Recruiting
Phase 1

Study of BHV-1300 in Graves' Disease

Graves Disease
Biohaven Therapeutics Ltd.15 enrolled13 locationsNCT06980649
Recruiting
Phase 1

A Study of GensSci098 in Subjects With Graves' Disease

SafetyGraves DiseaseTolerability+1 more
Changchun GeneScience Pharmaceutical Co., Ltd.24 enrolled1 locationNCT07286656
Recruiting
Not Applicable

Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

Thyroid CancerGraves Disease
University of Ulm60 enrolled1 locationNCT07410637
Recruiting
Phase 2

Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease

Graves Disease
Northwell Health30 enrolled1 locationNCT07369063
Recruiting
Not Applicable

Course for Brain Fatigue After Graves' Disease Controlled Study

Graves Disease
Vastra Gotaland Region96 enrolled1 locationNCT06134219
Recruiting
Not Applicable

The Impact of Person Centred Care (PCC) in Grave's Disease

Graves Disease
Vastra Gotaland Region220 enrolled1 locationNCT06309316
Recruiting
Not Applicable

Personalized Treatment in Thyroid Disorders

Thyroid CancerGraves Disease
Johns Hopkins University10 enrolled1 locationNCT03517579
Recruiting

Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

Graves DiseaseThyroid DiseasesAutoimmune Diseases+2 more
Vastra Gotaland Region180 enrolled1 locationNCT05678374
Recruiting
Not Applicable

Rubus Sanctus (Wild Blackberry) Root Extract as a Dietary Supplement for Graves' Disease

Graves Disease (Basedow's Disease)
Betul Uner42 enrolled1 locationNCT07164079
Recruiting
Not Applicable

Prospective Evaluation of OptiThyDose

Graves DiseaseThyroid DiseasesCongenital Hypothyroidism
University Children's Hospital Basel150 enrolled2 locationsNCT06864351
Recruiting
Early Phase 1

Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease

Graves Disease
Shanghai Zhongshan Hospital5 enrolled1 locationNCT07129642
Recruiting

Prevalence and Predictors of Incidental Thyroid Carcinoma in Patients With Graves' Disease Undergoing Thyroidectomy.

Thyroid CancerGraves Disease
Minia University280 enrolled1 locationNCT07059507
Recruiting

Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

Graves DiseaseAmiodarone-Induced Thyrotoxicosis
Andrea Goldmann486 enrolled15 locationsNCT06963203
Recruiting
Phase 4

Preoperative Corticosteroids in Autoimmune Thyroid Disease

Graves DiseaseHashimoto Disease
Indiana University76 enrolled3 locationsNCT05435547
Recruiting
Not Applicable

BASE-DIET: a Study on Nutritional Intervention in Patients With Graves' Disease

Graves Disease
Istituti Clinici Scientifici Maugeri SpA54 enrolled1 locationNCT06921304
Recruiting

Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease

Graves DiseaseMental Fatigue
Vastra Gotaland Region430 enrolled1 locationNCT06081439
Recruiting
Not Applicable

A Prospective Evaluation of Microwave Ablation (MWA) in the Treatment of Relapsed Graves' Disease

Graves DiseaseAblation TreatmentMinimally Invasive Treatment
The University of Hong Kong25 enrolled1 locationNCT06506149
Recruiting

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

CancerLymphomaLeukemia+44 more
Sanguine Biosciences20,000 enrolled1 locationNCT05635266